sulfonamide

Small moleculeexperimental

In organic chemistry, the sulfonamide functional group is an organosulfur group with the structure R−S(=O)2−NR2. It consists of a sulfonyl group connected to an amine group. Relatively speaking this group is unreactive. Because of the rigidity of the functional group, sulfonamides are typically crystalline; for this reason, the formation of a sulfonamide is a classic method to convert an amine into a crystalline derivative which can be identified by its melting point. Many important drugs contain the sulfonamide group. — Wikipedia

Clinical trial activity

3 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0

Earliest trial started Apr 1, 2000 (NCT00005864)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • sulfonamide
  • sulfonamide
  • sulfonamide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06607796Phase 3Mar 1, 2024Guangzhou Medical University
NCT00008372Phase 2Dec 1, 2000City of Hope National Medical Center, National Cancer Institute (NCI), University of California, Davis
NCT00005864Phase 2Apr 1, 2000National Cancer Institute (NCI), Ohio State University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government2012000
City of Hope National Medical CenterAcademic/Hospital1112000
Guangzhou Medical UniversityAcademic/Hospital1112024
Ohio State UniversityAcademic/Hospital1112000
University of California, DavisAcademic/Hospital1012000
5 organizations
Page 1 / 1